Loading clinical trials...
Loading clinical trials...
A Phase 1, Open Label Dose-Ranging Study to Assess the Safety, Tolerability, Preliminary Efficacy, and Dose Effect of CFL001 Cord Blood Product in Patients With Symptomatic Sacroiliac Joint Syndrome
Conditions
Interventions
PremierMaxCB®-Platinum (CFL001);
Locations
1
United States
University of Florida Pain Clinic
Gainesville, Florida, United States
Start Date
May 10, 2024
Primary Completion Date
January 15, 2027
Completion Date
March 6, 2028
Last Updated
January 20, 2026
NCT05058287
NCT05306665
NCT04640896
NCT05463367
NCT05043961
NCT06504797
Lead Sponsor
University of Florida
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions